Kyrillos Jean-Claude has filed 27 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 434 shares of TANDEM DIABETES CARE INC ($TNDM) on May 15, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Common Stock | 434 | $10.90 | 28,105.0000 | 68,325,927 | 1.57% | 0.00% |
| May 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Common Stock | 4038 | $0.00 | 29,810.0000 | 68,325,927 | 15.67% | 0.01% |
| May 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | F | Common Stock | 2139 | $12.82 | 27,671.0000 | 68,325,927 | 7.18% | 0.00% |
| May 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Restricted Stock Unit | 4038 | $0.00 | 8,077.0000 | 68,325,927 | 33.33% | 0.01% |
| April 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Common Stock | 3636 | $0.00 | 27,698.0000 | 68,325,927 | 15.11% | 0.01% |
| April 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Restricted Stock Unit | 3636 | $0.00 | 18,181.0000 | 68,325,927 | 16.67% | 0.01% |
| April 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | F | Common Stock | 1926 | $20.66 | 25,772.0000 | 68,325,927 | 6.95% | 0.00% |
| Jan. 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Common Stock | 3636 | $0.00 | 26,180.0000 | 67,802,359 | 16.13% | 0.01% |
| Jan. 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | F | Common Stock | 2118 | $21.07 | 24,062.0000 | 67,802,359 | 8.09% | 0.00% |
| Jan. 15, 2026 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Restricted Stock Unit | 3636 | $0.00 | 21,817.0000 | 67,802,359 | 14.29% | 0.01% |
| Nov. 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Common Stock | 160 | $15.59 | 22,544.0000 | 67,802,359 | 0.71% | 0.00% |
| Oct. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Restricted Stock Unit | 3636 | $0.00 | 25,453.0000 | 66,473,272 | 12.50% | 0.01% |
| Oct. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Common Stock | 3636 | $0.00 | 23,685.0000 | 66,473,272 | 18.14% | 0.01% |
| Oct. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | F | Common Stock | 1301 | $14.75 | 22,384.0000 | 66,473,272 | 5.49% | 0.00% |
| July 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Common Stock | 14545 | $0.00 | 25,254.0000 | 66,473,272 | 135.82% | 0.02% |
| July 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | F | Common Stock | 5205 | $15.20 | 20,049.0000 | 66,473,272 | 20.61% | 0.01% |
| July 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | M | Restricted Stock Unit | 14545 | $0.00 | 29,089.0000 | 66,473,272 | 33.33% | 0.02% |
| May 30, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Performance Stock Unit | 12114 | $0.00 | 12,114.0000 | 66,473,272 | 9999.99% | 0.02% |
| May 30, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Restricted Stock Unit | 12115 | $0.00 | 12,115.0000 | 66,473,272 | 9999.99% | 0.02% |
| May 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Common Stock | 171 | $19.30 | 10,709.0000 | 66,473,272 | 1.62% | 0.00% |
| March 7, 2025 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | P | Common Stock | 10538 | $18.12 | 10,538.0000 | 66,473,272 | 9999.99% | 0.02% |
| July 15, 2024 | TANDEM DIABETES CARE INC | $TNDM | Kyrillos Jean-Claude | EVP & Chief Operating Officer | A | Restricted Stock Unit | 43634 | $0.00 | 43,634.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2023 | Envista Holdings Corp | $NVST | Kyrillos Jean-Claude | Senior Vice President | A | Envista deferred contribution programs - Envista Stock Fund | 516 | $38.73 | 1,431.0000 | 177,600,000 | 56.39% | 0.00% |
| Feb. 25, 2023 | Envista Holdings Corp | $NVST | Kyrillos Jean-Claude | Senior Vice President | A | Performance Share Unit | 10095 | $0.00 | 10,095.0000 | 177,600,000 | 9999.99% | 0.01% |
| Feb. 25, 2023 | Envista Holdings Corp | $NVST | Kyrillos Jean-Claude | Senior Vice President | F | Common Stock | 2796 | $38.25 | 22,278.0000 | 177,600,000 | 11.15% | 0.00% |
| Feb. 25, 2023 | Envista Holdings Corp | $NVST | Kyrillos Jean-Claude | Senior Vice President | A | Common Stock | 5560 | $0.00 | 27,838.0000 | 177,600,000 | 24.96% | 0.00% |
| Feb. 25, 2023 | Envista Holdings Corp | $NVST | Kyrillos Jean-Claude | Senior Vice President | A | Employee Stock Option (Right to Buy) | 13340 | $0.00 | 13,340.0000 | 177,600,000 | 9999.99% | 0.01% |